-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 19, the State Food and Drug Administration issued a notice on 15 batches of drugs that did not meet the requirements
1.
According to the inspection by Fujian Food and Drug Quality Inspection Institute, a batch of chloramphenicol eye drops produced by Guangdong Hongying Technology Co.
According to the inspection by Shandong Food and Drug Inspection and Research Institute, a batch of brain spirit capsules produced by Jiangxi Yaodu Zhangshu Pharmaceutical Co.
According to the inspection by Beijing Institute for Drug Control, a batch of Xinnaoxin tablets produced by Hubei Ji'antang Pharmaceutical Co.
After inspection by Chongqing Food and Drug Inspection and Testing Research Institute, a batch of Zhuanggu Musk analgesic ointment produced by Jiuzhaigou Natural Pharmaceutical Group Co.
According to the inspection by Hubei Institute of Drug Administration and Inspection, a batch of Atractylodes japonicus produced by Beijing Boaitang Anguo Chinese Medicine Technology Co.
The 2 batches of Bupleurum produced by Guangxi Lanzheng Pharmaceutical Co.
2.
3.